Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug–microbiome interactions

References

• Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. 2001 Feb 15;409(6822):860–921. PubMed PMID: 11237011; eng.
   PubMed Web of Science ®Google Scholar
• Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science. 2001 Feb 16;291(5507):1304–1351. PubMed PMID: 11181995; eng.
   PubMed Web of Science ®Google Scholar
• Nelson NJ. Draft human genome sequence yields several surprises. J Natl Cancer Inst. 2001 Apr 4;93(7):493. PubMed PMID: 11287437; eng.
   PubMedGoogle Scholar
• Rizkallah MR, Saad R, Aziz RK. The human microbiome project, personalized medicine and the birth of pharmacomicrobiomics. Curr Pharmacogenomics Person Med. 2010;8(3):182–193.
   Google Scholar
• Relman DA, Falkow S. The meaning and impact of the human genome sequence for microbiology. Trends Microbiol. 2001 May;9(5):206–208. S0966-842X(01)02041-8 [pii]. PubMed PMID: 11336835; eng.
   PubMed Web of Science ®Google Scholar
• Richards CL, Bossdorf O, Verhoeven KJ. Understanding natural epigenetic variation. New Phytol. 2010 Aug;187(3):562–564. PubMed PMID: 20659249; eng.
   PubMed Web of Science ®Google Scholar
• Maher B. ENCODE: the human encyclopaedia. Nature. 2012 Sep 6;489(7414):46–48. PubMed PMID: 22962707; eng.
   PubMed Web of Science ®Google Scholar
• Kendall AI. Some observations on the study of the intestinal bacteria. J Biol Chem. 1909 Nov 1;6:499–507.
   Google Scholar
• Aziz RK. A hundred-year-old insight into the gut microbiome! Gut Pathog. 2009;11:21. PubMed PMID: 19968883; PubMed Central PMCID: PMC2797815. eng
   PubMedGoogle Scholar
• Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006 Jun 2;312(5778):1355–1359. PubMed PMID: 16741115.
   PubMed Web of Science ®Google Scholar
• Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol. 1977;31:107–133. PubMed PMID: 334036; eng.
   PubMed Web of Science ®Google Scholar
• Pflughoeft KJ, Versalovic J. Human microbiome in health and disease. Annu Rev Pathol. 2012;7:99–122. PubMed PMID: 21910623; eng.
   PubMed Web of Science ®Google Scholar
• Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006 Feb 24;124(4):837–848. PubMed PMID: 16497592; eng.
   PubMed Web of Science ®Google Scholar
• Cheesman SE, Guillemin K. We know you are in there: conversing with the indigenous gut microbiota. Res Microbiol. 2007 Jan-Feb;158(1):2–9. PubMed PMID: 17223317; eng.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature. 2007 Oct 18;449(7164):804–810. PubMed PMID: 17943116.
   PubMed Web of Science ®Google Scholar
• Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010 Mar 4;464(7285):59–65. PubMed PMID: 20203603; eng.
   PubMed Web of Science ®Google Scholar
• Sousa T, Paterson R, Moore V, et al. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm. 2008 Nov 3;363(1–2):1–25. PubMed PMID: 18682282; eng.
   PubMed Web of Science ®Google Scholar
• Wilson ID, Nicholson JK. The role of gut microbiota in drug response. Curr Pharm Des. 2009;15(13): 1519–1523. PubMed PMID: 19442168; eng.
   PubMed Web of Science ®Google Scholar
• Haiser HJ, Turnbaugh PJ. Developing a metagenomic view of xenobiotic metabolism. Pharmacol Res. 2013 Mar;69(1):21–31. PubMed PMID: 22902524; PubMed Central PMCID: PMC3526672. eng.
   PubMed Web of Science ®Google Scholar
• Clayton TA, Lindon JC, Cloarec O, et al. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature. 2006 Apr 20;440(7087):1073–1077. PubMed PMID: 16625200; eng.
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Wilson ID, Lindon JC. Pharmacometabonomics as an effector for personalized medicine. Pharmacogenomics. 2011 Jan;12(1):103–111. PubMed PMID: 21174625; eng.
   PubMed Web of Science ®Google Scholar
• ElRakaiby M, Dutilh BE, Rizkallah MR, et al. Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics. OMICS. 2014 Jul;18(7):402–414. PubMed PMID: 24785449; PubMed Central PMCID: PMC4086029. eng.
   PubMed Web of Science ®Google Scholar
• Sleator RD. The human superorganism - of microbes and men. Med Hypotheses. 2010 Feb;74(2):214–215. PubMed PMID: 19836146; eng.
   PubMed Web of Science ®Google Scholar
• Aziz RK. Rethinking pharmacogenomics in an ecosystem: drug-microbiome interactions, pharmacomicrobiomics, and personalized medicine for the human supraorganism. Curr Pharmacogenomics Person Med. 2012;10(4):258–261.
   Google Scholar
• Johnson CH, Patterson AD, Idle JR, et al. Xenobiotic metabolomics: major impact on the metabolome. Annu Rev Pharmacol Toxicol. 2012 Feb 10;52:37–56. PubMed PMID: 21819238; eng.
   PubMed Web of Science ®Google Scholar
• Tralau T, Sowada J, Luch A. Insights on the human microbiome and its xenobiotic metabolism: what is known about its effects on human physiology? Expert Opin Drug Metab Toxicol. 2015 Mar;11(3):411–425. PubMed PMID: 25476418; eng.
   PubMed Web of Science ®Google Scholar
• Peterson J, Garges S, Giovanni M, et al. The NIH human microbiome project. Genome Res. 2009 Dec;19(12):2317–2323. PubMed PMID: 19819907; PubMed Central PMCID: PMC2792171. eng.
   PubMed Web of Science ®Google Scholar
• Integrative HMP (iHMP) Research Network Consortium. The integrative human microbiome project: dynamic analysis of microbiome-host omics profiles during periods of human health and disease. Cell Host Microbe. 2014 Sep 10;16(3):276–289. PubMed PMID: 25211071; PubMed Central PMCID: PMC5109542. eng.
   PubMed Web of Science ®Google Scholar
• Lloyd-Price J, Mahurkar A, Rahnavard G, et al. Strains, functions and dynamics in the expanded human microbiome project. Nature. 2017 Oct 5;550(7674):61–66. PubMed PMID: 28953883; PubMed Central PMCID: PMC5831082. eng.
   PubMed Web of Science ®Google Scholar
• Ley RE, Knight R, Gordon JI. The human microbiome: eliminating the biomedical/environmental dichotomy in microbial ecology. Environ Microbiol. 2007 Jan;9(1):3–4. PubMed PMID: 17227400.
   PubMed Web of Science ®Google Scholar
• Nolen RS. Mahr calls for ‘one health’ initiative. J Am Vet Med Assoc. 2006 Sep 1;229(5):640. PubMed PMID: 16972371; eng.
   PubMedGoogle Scholar
• Evans BR, Leighton FA. A history of one health. Rev Sci Tech. 2014 Aug;33(2):413–420. PubMed PMID: 25707172; eng.
   PubMed Web of Science ®Google Scholar
• Huse SM, Ye Y, Zhou Y, et al. A core human microbiome as viewed through 16S rRNA sequence clusters. PLoS ONE. 2012;7(6):e34242. PONE-D-12-04736 [pii]. PubMed PMID: 22719824; PubMed Central PMCID: PMC3374614. eng.
   PubMed Web of Science ®Google Scholar
• Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012 Jun 14;486(7402):207–214. PubMed PMID: 22699609; eng.
   PubMed Web of Science ®Google Scholar
• Hyde ER, Andrade F, Vaksman Z, et al. Metagenomic analysis of nitrate-reducing bacteria in the oral cavity: implications for nitric oxide homeostasis. PLoS ONE. 2014;9(3):e88645. PubMed PMID: 24670812; PubMed Central PMCID: PMC3966736. eng.
   PubMed Web of Science ®Google Scholar
• Martens EC, Lowe EC, Chiang H, et al. Recognition and degradation of plant cell wall polysaccharides by two human gut symbionts. PLoS Biol. 2011 Dec;9(12):e1001221. PubMed PMID: 22205877; PubMed Central PMCID: PMC3243724. eng.
   PubMed Web of Science ®Google Scholar
• Cuskin F, Lowe EC, Temple MJ, et al. Human gut Bacteroidetes can utilize yeast mannan through a selfish mechanism. Nature. 2015 Jan 8;517(7533):165–169. PubMed PMID: 25567280; PubMed Central PMCID: PMC4978465. eng.
   PubMed Web of Science ®Google Scholar
• Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature. 2011 May 12;473(7346):174–180. PubMed PMID: 21508958; PubMed Central PMCID: PMC3728647.
   PubMed Web of Science ®Google Scholar
• Siezen RJ, Kleerebezem M. The human gut microbiome: are we our enterotypes? Microb Biotechnol. 2011 Sep 4;(5):550–553. PubMed PMID: 21848611; eng.
   PubMed Web of Science ®Google Scholar
• Li M, Wang B, Zhang M, et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA. 2008 Feb 12;105(6):2117–2122. PubMed PMID: 18252821; PubMed Central PMCID: PMC2538887. eng.
   PubMed Web of Science ®Google Scholar
• Kaddurah-Daouk R, Weinshilboum RM. Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology. Clin Pharmacol Ther. 2014 Feb;95(2):154–167. PubMed PMID: 24193171; eng.
   PubMed Web of Science ®Google Scholar
• Guthrie L, Gupta S, Daily J, et al. Human microbiome signatures of differential colorectal cancer drug metabolism. NPJ Biofilms Microbiomes. 2017;3:27. PubMed PMID: 29104759; PubMed Central PMCID: PMC5665930. eng.
   PubMed Web of Science ®Google Scholar
• David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014 Jan 23;505(7484):559–563. PubMed PMID: 24336217; PubMed Central PMCID: PMC3957428. eng.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006 Dec 21;444(7122):1027–1031. PubMed PMID: 17183312; eng.
   PubMed Web of Science ®Google Scholar
• Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004 Nov 2;101(44):15718–15723. PubMed PMID: 15505215; PubMed Central PMCID: PMC524219. eng.
   PubMed Web of Science ®Google Scholar
• Luca F, Kupfer SS, Knights D, et al. Functional genomics of host-microbiome interactions in humans. Trends Genet. 2018 Jan;34(1):30–40. PubMed PMID: 29107345; PubMed Central PMCID: PMC5774629. eng.
   PubMed Web of Science ®Google Scholar
• Kolde R, Franzosa EA, Rahnavard G, et al. Host genetic variation and its microbiome interactions within the human microbiome project. Genome Med. 2018 Jan 29;10(1):6. PubMed PMID: 29378630; PubMed Central PMCID: PMC5789541. eng.
   PubMedGoogle Scholar
• Comerford KB, Pasin G. Gene-dairy food interactions and health outcomes: A review of nutrigenetic studies. Nutrients. 2017 Jul 6;9(7). PubMed PMID: 28684688; PubMed Central PMCID: PMC5537825. eng. DOI: 10.3390/nu9070710.
   PubMed Web of Science ®Google Scholar
• Nayak RR, Turnbaugh PJ. Mirror, mirror on the wall: which microbiomes will help heal them all? BMC Med. 2016 May 4;14:72.
   PubMed Web of Science ®Google Scholar
• Kaddurah-Daouk R, Kristal BS, Weinshilboum RM. Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol. 2008;48:653–683. PubMed PMID: 18184107; eng.
   PubMed Web of Science ®Google Scholar
• Clayton TA, Baker D, Lindon JC, et al. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci USA. 2009 Aug 25;106(34):14728–14733. PubMed PMID: 19667173; PubMed Central PMCID: PMC2731842. eng.
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Wilson ID. Opinion: understanding ‘global’ systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov. 2003 Aug;2(8):668–676. PubMed PMID: 12904817; eng.
   PubMed Web of Science ®Google Scholar
• Ibrahim M, Anishetty S. A meta-metabolome network of carbohydrate metabolism: interactions between gut microbiota and host. Biochem Biophys Ress Commun. 2012 Nov 16;428(2):278–284. PubMed PMID: 23085046; eng.
   PubMed Web of Science ®Google Scholar
• Rosato A, Tenori L, Cascante M, et al. From correlation to causation: analysis of metabolomics data using systems biology approaches. Metabolomics. 2018;14(4):37. PubMed PMID: 29503602; PubMed Central PMCID: PMC5829120. eng.
   PubMed Web of Science ®Google Scholar
• Walker AW. Studying the human microbiota. In: Schwiertz A, editor. Microbiota of the human body. Advances in experimental medicine and biology. Vol. 902. 2016/05/11ed. Cham, Switzerland: Springer; 2016. p. 5–32.
   Google Scholar
• McWhinney SR, McLeod HL. Using germline genotype in cancer pharmacogenetic studies. Pharmacogenomics. 2009 Mar;10(3):489–493. PubMed PMID: 19650256; PubMed Central PMCID: PMC2722037. eng.
   PubMed Web of Science ®Google Scholar
• Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol. 2005 Dec;71(12):8228–8235. PubMed PMID: 16332807; PubMed Central PMCID: PMC1317376. eng.
   PubMed Web of Science ®Google Scholar
• Mumby PJ. Beta and habitat diversity in marine systems: a new approach to measurement, scaling and interpretation. Oecologia. 2001 Jul;128(2):274–280. PubMed PMID: 28547476; eng.
   PubMed Web of Science ®Google Scholar
• Haiser HJ, Gootenberg DB, Chatman K, et al. Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science. 2013 Jul 19;341(6143):295–298. PubMed PMID: 23869020; PubMed Central PMCID: PMC3736355. eng.
   PubMed Web of Science ®Google Scholar
• Rizkallah MR, Gamal-Eldin S, Saad R, et al. The pharmacomicrobiomics portal: a database for drug-microbiome interactions. Curr Pharmacogenomics Person Med. 2012 Sep 1;10(3):195–203.
   Google Scholar
• Sharma AK, Jaiswal SK, Chaudhary N, et al. A novel approach for the prediction of species-specific biotransformation of xenobiotic/drug molecules by the human gut microbiota. Sci Rep. 2017 Aug 29;7(1):9751. PubMed PMID: 28852076; PubMed Central PMCID: PMC5575299. eng.
   PubMedGoogle Scholar
• Langille MG, Zaneveld J, Caporaso JG, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013 Sep;31(9):814–821. PubMed PMID: 23975157; PubMed Central PMCID: PMC3819121. eng.
   PubMed Web of Science ®Google Scholar
• Eng A, Borenstein E. An algorithm for designing minimal microbial communities with desired metabolic capacities. Bioinformatics. 2016 Jul 1;32(13):2008–2016. PubMed PMID: 27153571; PubMed Central PMCID: PMC4920118. eng.
   PubMed Web of Science ®Google Scholar
• Noecker C, Eng A, Srinivasan S, et al. Metabolic model-based integration of microbiome taxonomic and metabolomic profiles elucidates mechanistic links between ecological and metabolic variation. mSystems. 2016 Jan-Feb;1(1). PubMed PMID: 27239563; PubMed Central PMCID: PMC4883586. eng. DOI:10.1128/mSystems.00013-15.
   PubMed Web of Science ®Google Scholar
• Manor O, Borenstein E. Systematic characterization and analysis of the taxonomic drivers of functional shifts in the human microbiome. Cell Host Microbe. 2017 Feb 8;21(2):254–267. PubMed PMID: 28111203; PubMed Central PMCID: PMC5316541. eng.
   PubMed Web of Science ®Google Scholar
• McNally CP, Eng A, Noecker C, et al. BURRITO: an interactive multi-omic tool for visualizing taxa-function relationships in microbiome data. Front Microbiol. 2018;9:365. PubMed PMID: 29545787; PubMed Central PMCID: PMC5837987. eng.
   PubMed Web of Science ®Google Scholar
• Gong S, Lan T, Zeng L, et al. Gut microbiota mediates diurnal variation of acetaminophen induced acute liver injury in mice. J Hepatol. 2018 Mar 8 PubMed PMID: 29524531; eng. DOI:10.1016/j.jhep.2018.02.024.
   PubMed Web of Science ®Google Scholar
• Aziz RK, Saad R, Rizkallah MR. PharmacoMicrobiomics or how bugs modulate drugs: an educational initiative to explore the effects of human microbiome on drugs. BMC Bioinformatics. 2011;12(Suppl 7):A10.
   PubMedGoogle Scholar
• Napolitano A, Miller S, Nicholls AW, et al. Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus. PLoS ONE. 2014;9(7):e100778. PubMed PMID: 24988476; PubMed Central PMCID: PMC4079657. eng.
   PubMed Web of Science ®Google Scholar
• Mathan VI, Wiederman J, Dobkin JF, et al. Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora. Gut. 1989 Jul;30(7):971–977. PubMed PMID: 2759492; PubMed Central PMCID: PMC1434295. eng.
   PubMed Web of Science ®Google Scholar
• Dobkin JF, Saha JR, Butler VP Jr., et al. Inactivation of digoxin by Eubacterium lentum, an anaerobe of the human gut flora. Trans Assoc Am Physicians. 1982;95:22–29, PubMed PMID: 7182977; eng
   PubMedGoogle Scholar
• Koppel N, Bisanz JE, Pandelia ME, et al. Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins. Elife. 2018 May 15;7. PubMed PMID: 29761785; PubMed Central PMCID: PMC5953540. eng.
   PubMed Web of Science ®Google Scholar
• Viaud S, Saccheri F, Mignot G, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 2013 Nov 22;342(6161):971–976. PubMed PMID: 24264990; eng.
   PubMed Web of Science ®Google Scholar
• Haiser HJ, Turnbaugh PJ. Is it time for a metagenomic basis of therapeutics? Science. 2012 Jun 8;336(6086):1253–1255. PubMed PMID: 22674325; eng.
   PubMed Web of Science ®Google Scholar
• Gilbert JA, Quinn RA, Debelius J, et al. Microbiome-wide association studies link dynamic microbial consortia to disease. Nature. 2016 Jul 7;535(7610):94–103. PubMed PMID: 27383984; eng.
   PubMed Web of Science ®Google Scholar
• Spanogiannopoulos P, Bess EN, Carmody RN, et al. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol. 2016 Apr;14(5):273–287. PubMed PMID: 26972811; PubMed Central PMCID: PMC5243131. eng.
   PubMed Web of Science ®Google Scholar
• Patterson AD, Turnbaugh PJ. Microbial determinants of biochemical individuality and their impact on toxicology and pharmacology. Cell Metab. 2014 Nov 4;20(5):761–768. PubMed PMID: 25156450; PubMed Central PMCID: PMC4252706. eng.
   PubMed Web of Science ®Google Scholar
• Choi MS, Yu JS, Yoo HH, et al. The role of gut microbiota in the pharmacokinetics of antihypertensive drugs. Pharmacol Res. 2018 Jan 30 PubMed PMID: 29391236; eng. DOI:10.1016/j.phrs.2018.01.019.
   Web of Science ®Google Scholar
• Yi M, Yu S, Qin S, et al. Gut microbiome modulates efficacy of immune checkpoint inhibitors. J Hematol Oncol. 2018 Mar 27;11(1):47. PubMed PMID: 29580257; PubMed Central PMCID: PMC5870075. eng.
   PubMedGoogle Scholar
• Alexander JL, Wilson ID, Teare J, et al. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol. 2017 Jun;14(6):356–365. PubMed PMID: 28270698; eng.
   PubMed Web of Science ®Google Scholar
• Bisanz JE, Spanogiannopoulos P, Pieper LM, et al. How to determine the role of the microbiome in drug disposition. Drug Metab Dispos. 2018 Aug 15. PubMed PMID: 30111623; eng. DOI:10.1124/dmd.118.083402.
   PubMedGoogle Scholar
• Yoo HH, Kim IS, Yoo DH, et al. Effects of orally administered antibiotics on the bioavailability of amlodipine: gut microbiota-mediated drug interaction. J Hypertens. 2016 Jan;34(1):156–162. PubMed PMID: 26630218; eng.
   PubMed Web of Science ®Google Scholar
• Song SC, An YM, Shin JH, et al. Beneficial effects of a probiotic blend on gastrointestinal side effects induced by leflunomide and amlodipine in a rat model. Benef Microbes. 2017 Oct 13;8(5):801–808. PubMed PMID: 28969447; eng.
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen Y, Sun Y, et al. Plateau hypoxia attenuates the metabolic activity of intestinal flora to enhance the bioavailability of nifedipine. Drug Deliv. 2018 Nov;25(1):1175–1181. PubMed PMID: 29790376; eng.
   PubMed Web of Science ®Google Scholar
• Romano KA, Vivas EI, Amador-Noguez D, et al. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. MBio. 2015 Mar 17;6(2):e02481. PubMed PMID: 25784704; PubMed Central PMCID: PMC4453578. eng.
   PubMed Web of Science ®Google Scholar
• Yoo DH, Kim IS, Van Le TK, et al. Gut microbiota-mediated drug interactions between lovastatin and antibiotics. Drug Metab Dispos. 2014 Sep;42(9):1508–1513. PubMed PMID: 24947972; eng.
   PubMed Web of Science ®Google Scholar
• Williams BB, Van Benschoten AH, Cimermancic P, et al. Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host Microbe. 2014 Oct 8;16(4):495–503. PubMed PMID: 25263219; PubMed Central PMCID: PMC4260654. eng.
   PubMed Web of Science ®Google Scholar
• Rothhammer V, Borucki DM, Tjon EC, et al. Microglial control of astrocytes in response to microbial metabolites. Nature. 2018 May;557(7707):724–728. .
   PubMed Web of Science ®Google Scholar
• Feng R, Shou JW, Zhao ZX, et al. Transforming berberine into its intestine-absorbable form by the gut microbiota. Sci Rep. 2015 Jul 15;5:12155. PubMed PMID: 26174047; PubMed Central PMCID: PMC4502414. eng.
   PubMed Web of Science ®Google Scholar
• Wang D, Ho L, Faith J, et al. Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer’s disease beta-amyloid oligomerization. Mol Nutr Food Res. 2015 Jun;59(6):1025–1040. PubMed PMID: 25689033; PubMed Central PMCID: PMC4498582. eng.
   PubMed Web of Science ®Google Scholar
• Biernat KA, Li B, Redinbo MR. Microbial unmasking of plant glycosides. MBio. 2018 Jan 30;9(1). PubMed PMID: 29382739; PubMed Central PMCID: PMC5790921. eng. DOI:10.1128/mBio.02433-17.
   PubMed Web of Science ®Google Scholar
• Theilmann MC, Goh YJ, Nielsen KF, et al. Lactobacillus acidophilus metabolizes dietary plant glucosides and externalizes their bioactive phytochemicals. MBio. 2017 Nov 21;8(6). PubMed PMID: 29162708; PubMed Central PMCID: PMC5698550. eng.
   PubMed Web of Science ®Google Scholar
• Bang SH, Hyun YJ, Shim J, et al. Metabolism of rutin and poncirin by human intestinal microbiota and cloning of their metabolizing alpha-L-rhamnosidase from Bifidobacterium dentium. J Microbiol Biotechnol. 2015 Jan;25(1):18–25. PubMed PMID: 25179902; eng.
   PubMed Web of Science ®Google Scholar
• Lin XB, Farhangfar A, Valcheva R, et al. The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats. PLoS ONE. 2014;9(1):e83644. PubMed PMID: 24454707; PubMed Central PMCID: PMC3891650. eng.
   PubMed Web of Science ®Google Scholar
• Shen S, Lim G, You Z, et al. Gut microbiota is critical for the induction of chemotherapy-induced pain. Nat Neurosci. 2017 Sep;20(9):1213–1216. PubMed PMID: 28714953; PubMed Central PMCID: PMC5575957. eng.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Sarrias A, Tome-Carneiro J, Bellesia A, et al. The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells. Food Funct. 2015 May;6(5):1460–1469. PubMed PMID: 25857357; eng.
   PubMed Web of Science ®Google Scholar
• Kaiser J. Gut microbes shape response to cancer immunotherapy. Science. 2017 Nov 3;358(6363):573. PubMed PMID: 29097525; eng.
   PubMed Web of Science ®Google Scholar
• Sivan A, Corrales L, Hubert N, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015 Nov 27;350(6264):1084–1089. PubMed PMID: 26541606; PubMed Central PMCID: PMC4873287. eng.
   PubMed Web of Science ®Google Scholar
• Dubin K, Callahan MK, Ren B, et al. Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis. Nat Commun. 2016 Feb 2;7:10391. PubMed PMID: 26837003; PubMed Central PMCID: PMC4740747. eng.
   PubMed Web of Science ®Google Scholar
• Yan A, Culp E, Perry J, et al. Transformation of the anticancer drug Doxorubicin in the human gut microbiome. ACS Infect Dis. 2018 Jan 12;4(1):68–76. PubMed PMID: 29160065; eng.
   PubMed Web of Science ®Google Scholar
• Sun P, Chen JY, Li J, et al. The protective effect of geniposide on human neuroblastoma cells in the presence of formaldehyde. BMC Complement Altern Med. 2013 Jul 1;13:152. PubMed PMID: 23815892; PubMed Central PMCID: PMC3702466. eng.
   PubMed Web of Science ®Google Scholar
• Jin MJ, Kim IS, Kim DH, et al. Effects of intestinal microbiota on the bioavailability of geniposide in rats. J Agric Food Chem. 2014 Oct 8;62(40):9632–9636. PubMed PMID: 25257195; eng.
   PubMed Web of Science ®Google Scholar
• Khanal T, Kim HG, Choi JH, et al. Biotransformation of geniposide by human intestinal microflora on cytotoxicity against HepG2 cells. Toxicol Lett. 2012 Mar 25;209(3):246–254. PubMed PMID: 22245672; eng.
   PubMed Web of Science ®Google Scholar
• Kodawara T, Higashi T, Negoro Y, et al. The inhibitory effect of ciprofloxacin on the beta-glucuronidase-mediated deconjugation of the irinotecan metabolite SN-38-G. Basic Clin Pharmacol Toxicol. 2016 May;118(5):333–337. PubMed PMID: 26518357; eng.
   PubMed Web of Science ®Google Scholar
• Wallace BD, Roberts AB, Pollet RM, et al. Structure and inhibition of microbiome beta-glucuronidases essential to the alleviation of cancer drug toxicity. Chem Biol. 2015 Sep 17;22(9):1238–1249. PubMed PMID: 26364932; PubMed Central PMCID: PMC4575908. eng.
   PubMedGoogle Scholar
• Kong R, Liu T, Zhu X, et al. Old drug new use–amoxapine and its metabolites as potent bacterial beta-glucuronidase inhibitors for alleviating cancer drug toxicity. Clin Cancer Res. 2014 Jul 1;20(13):3521–3530. PubMed PMID: 24780296; PubMed Central PMCID: PMC4079752. eng.
   PubMed Web of Science ®Google Scholar
• Klatt NR, Cheu R, Birse K, et al. Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women. Science. 2017 Jun 2;356(6341):938–945. PubMed PMID: 28572388; eng.
   PubMed Web of Science ®Google Scholar
• Geller LT, Straussman R. Intratumoral bacteria may elicit chemoresistance by metabolizing anticancer agents. Mol Cell Oncol. 2018;5(1):e1405139. PubMed PMID: 29404397; PubMed Central PMCID: PMC5791857. eng.
   PubMed Web of Science ®Google Scholar
• Geller LT, Barzily-Rokni M, Danino T, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017 Sep 15;357(6356):1156–1160. PubMed PMID: 28912244; eng.
   PubMed Web of Science ®Google Scholar
• Vande Voorde J, Vervaeke P, Liekens S, et al. Mycoplasma hyorhinis-encoded cytidine deaminase efficiently inactivates cytosine-based anticancer drugs. FEBS Open Bio. 2015;5:634–639. PubMed PMID: 26322268; PubMed Central PMCID: PMC4541722. eng.
   PubMed Web of Science ®Google Scholar
• Velazquez YF, Nacheva PM. Biodegradability of fluoxetine, mefenamic acid, and metoprolol using different microbial consortiums. Environ Sci Pollut Res Int. 2017 Mar;24(7):6779–6793. PubMed PMID: 28091995; eng.
   PubMed Web of Science ®Google Scholar
• Zhang L, Xie C, Nichols RG, et al. Farnesoid X receptor signaling shapes the gut microbiota and controls hepatic lipid metabolism. mSystems. 2016 Sep-Oct;1(5). PubMed PMID: 27822554; PubMed Central PMCID: PMC5080402. eng. DOI:10.1128/mSystems.00070-16.
   PubMed Web of Science ®Google Scholar
• Gao B, Chi L, Mahbub R, et al. Multi-omics reveals that lead exposure disturbs gut microbiome development, key metabolites, and metabolic pathways. Chem Res Toxicol. 2017 Apr 17;30(4):996–1005. PubMed PMID: 28234468; PubMed Central PMCID: PMC5654721. eng.
   PubMed Web of Science ®Google Scholar
• Nichols D, Cahoon N, Trakhtenberg EM, et al. Use of ichip for high-throughput in situ cultivation of “uncultivable” microbial species. Appl Environ Microbiol. 2010 Apr;76(8):2445–2450. PubMed PMID: 20173072; PubMed Central PMCID: PMC2849220. eng.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Kawasaki K, Daimon S, et al. A hidden pitfall in the preparation of agar media undermines microorganism cultivability. Appl Environ Microbiol. 2014 Dec;80(24):7659–7666. PubMed PMID: 25281372; PubMed Central PMCID: PMC4249246. eng.
   PubMed Web of Science ®Google Scholar
• Penalver Bernabe B, Cralle L, Gilbert JA. Systems biology of the human microbiome. Curr Opin Biotechnol. 2018 Jun;51:146–153. PubMed PMID: 29453029; eng.
   PubMed Web of Science ®Google Scholar